Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2

BACKGROUND & AIMS: The albumin–bilirubin (ALBI) grade/score is derived from a validated nomogram to objectively assess prognosis and liver function in patients with hepatocellular carcinoma (HCC). In this post hoc analysis, we assessed prognosis in terms of survival by baseline ALBI grade and mo...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:JHEP Rep
Main Authors: Kudo, Masatoshi, Galle, Peter R., Brandi, Giovanni, Kang, Yoon-Koo, Yen, Chia-Jui, Finn, Richard S., Llovet, Josep M., Assenat, Eric, Merle, Philippe, Chan, Stephen L., Palmer, Daniel H., Ikeda, Masafumi, Yamashita, Tatsuya, Vogel, Arndt, Huang, Yi-Hsiang, Abada, Paolo B., Yoshikawa, Reigetsu, Shinozaki, Kenta, Wang, Chunxiao, Widau, Ryan C., Zhu, Andrew X.
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier 2020
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7772786/
https://ncbi.nlm.nih.gov/pubmed/33392490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2020.100215
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים